Haematopoietic development and leukaemia in Down syndrome
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Summary: Children with constitutional trisomy 21 (cT 21, D own S yndrome, DS) are at a higher risk for both myeloid and B‐lymphoid leukaemias. The myeloid leukaemias are often preceded by a transient neonatal pre‐leukaemic syndrome, T ransient A bnormal M yelopoiesis (TAM). TAM is caused by cooperation between c T 21 and acquired somatic N‐terminal truncating mutations in the key haematopoietic transcription factor GATA 1. These mutations, which are not leukaemogenic in the absence of c T 21, are found in almost one‐third of neonates with DS. Analysis of primary human fetal liver haematopoietic cells and of human embryonic stem cells demonstrates that c T 21 itself substantially alters human fetal haematopoietic development. Consequently, many haematopoietic developmental defects are observed in neonates with DS even in the absence of TAM. Although studies in mouse models have suggested a pathogenic role of deregulated expression of several chromosome 21‐encoded genes, their role in human leukaemogenesis remains unclear. As c T 21 exists in all embryonic cells, the molecular basis of c T 21‐associated leukaemias probably reflects a complex interaction between deregulated gene expression in haematopoietic cells and the fetal haematopoietic microenvironment in DS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutational Processes Molding the Genomes of 21 Breast Cancers
Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909
Korbel, J. O., Tirosh-Wagner, T., Urban, A. E., Chen, X.-N., Kasowski, M., Dai, L., Grubert, F., Erdman, C., Gao, M. C., Lange, K., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813248106 · Cited by 399 · cited 2×
“They identified an 8 5 Mb region on Hsa21 linked to leukaemia risk which included several genes, such as RUNX1, ERG and ETS2, known to be associated with acute leukaemia (Korbel et al, 2009).”
BackgroundMethodExome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia
Sankaran, V. G., Ghazvinian, R., Do, R., Thiru, P., Vergilio, J.-A., Beggs, A. H., Sieff, C. A., Orkin, S. H., Nathan, D. G., Lander, E. S., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63597 · Cited by 342
Aït Yahya-Graison, E., Aubert, J., Dauphinot, L., Rivals, I., Prieur, M., Golfier, G., Rossier, J., Personnaz, L., Créau, N., Bléhaut, H., et al. (2007) · The American Journal of Human Genetics · doi:10.1086/520000 · Cited by 338 · cited 2×
“…as well as DS leukaemias, an average 1 5-fold increased level of expression of Hsa21 genes in trisomic compared to disomic samples has been reported (Dauphinot et al, 2005; Ait-Yahya-Graison et al, 2007; Conti et al, 2007; Hertzberg et al, 2007, 2010; Prandini et al, 2007; Lockstone et al, 2007).”
BackgroundRUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.
Elagib, K. E., Racke, F. K., Mogass, M., Khetawat, R., Delehanty, L. L., & Goldfarb, A. N. (2003) · Blood · doi:10.1182/blood-2002-09-2708 · Cited by 332
Domains of genome-wide gene expression dysregulation in Down’s syndrome
Letourneau, A., Santoni, F. A., Bonilla, X., Sailani, M. R., Gonzalez, D., Kind, J., Chevalier, C., Thurman, R., Sandstrom, R. S., Hibaoui, Y., et al. (2014) · Nature · doi:10.1038/nature13200 · Cited by 319 · cited 2×
“…gene dosage of one or more Hsa21 genes important for HSPC proliferation, differentiation or survival (Table IV) although a recent study makes it clear that Hsa21 potentially alters the expression of multiple genes on virtually any (or all) of the disomic chromosomes (Letourneau et al, 2014).”
BackgroundGene expression profiling in the adult Down syndrome brain
Lockstone, H. E., Harris, L. W., Swatton, J. E., Wayland, M. T., Holland, A. J., & Bahn, S. (2007) · Genomics · doi:10.1016/j.ygeno.2007.08.005 · Cited by 240 · cited 1×
“…as well as DS leukaemias, an average 1 5-fold increased level of expression of Hsa21 genes in trisomic compared to disomic samples has been reported (Dauphinot et al, 2005; Ait-Yahya-Graison et al, 2007; Conti et al, 2007; Hertzberg et al, 2007, 2010; Prandini et al, 2007; Lockstone et al, 2007).”
BackgroundGribble, S. M., Wiseman, F. K., Clayton, S., Prigmore, E., Langley, E., Yang, F., Maguire, S., Fu, B., Rajan, D., Sheppard, O., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060482 · Cited by 102 · cited 1×
“More recently, multiple structural rearrangements/deletions have been identified in Tc1 mice, which may help to better refine the contribution of individual genes as it is now clear that 50 of the Hsa21 genes in this model, including RUNX1, are disomic (Gribble et al, 2013).”
Background
Cited by
Trisomy 21 consistently activates the interferon response
Sullivan, K. D., Lewis, H. C., Hill, A. A., Pandey, A., Jackson, L. P., Cabral, J. M., Smith, K. P., Liggett, L. A., Gomez, E. B., Galbraith, M. D., et al. (2016) · eLife · doi:10.7554/elife.16220 · Cited by 362
“…(e.g. solid tumors, hypertension), while strongly predisposing them to others (e.g. Alzheimer’s disease, leukemia, autoimmune disorders) (Alexander et al., 2016; Sobey et al., 2015; Bratman et al., 2014; Roberts and Izraeli, 2014; Anwar et al., 1998; Malinge et al., 2013; Hasle et al., 2016).”
BackgroundRipperger, T., Bielack, S. S., Borkhardt, A., Brecht, I. B., Burkhardt, B., Calaminus, G., Debatin, K., Deubzer, H., Dirksen, U., Eckert, C., et al. (2017) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38142 · Cited by 283
MicroRNA-486-5p is an erythroid oncomiR of the myeloid leukemias of Down syndrome.
Shaham, L., Vendramini, E., Ge, Y., Goren, Y., Birger, Y., Tijssen, M. R., McNulty, M., Geron, I., Schwartzman, O., Goldberg, L., et al. (2015) · Blood · doi:10.1182/blood-2014-06-581892 · Cited by 74
Self-citationGonzales, P. K., Roberts, C. M., Fonte, V., Jacobsen, C., Stein, G. H., & Link, C. D. (2018) · PLOS ONE · doi:10.1371/journal.pone.0194581 · Cited by 45
“If the gene dosage burden imposed by chromosome 21 trisomy generally interferes with the maintenance of stem cell fate, this might account for some Down syndrome clinical phenotypes, including the hematopoietic developmental defects observed in DS [39].”
Background
Metadata
- Authors
- Roberts, I., & Izraeli, S.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 2014-08-22
- Volume
- 167
- Issue
- 5
- Pages
- 587-599
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W1979630015
- Cited by
- 107
- References
- 8
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.